
Wellmarker Bio
Developer of anticancer drugs designed to treat cancer patients with medical advancement. The company specializes in developing predictive biomarkers and first-in-class drugs through profound research...
Valuation
$0
Share Price
N/A
Total Raised
$41.9M
Last Round
N/A